➡️ https://l.ici.fr/sdhB
➡️ https://l.ici.fr/sdhB
SDHB-deficient kidney cancer is a rare but highly aggressive tumor, often striking patients at a younger age—typically in their 30s and 40s. 🧬 Linked to hereditary mutations in the SDHB gene, it carries a poor prognosis.
SDHB-deficient kidney cancer is a rare but highly aggressive tumor, often striking patients at a younger age—typically in their 30s and 40s. 🧬 Linked to hereditary mutations in the SDHB gene, it carries a poor prognosis.
Here, Justin P. Annes & team report an SDHB-specific assay that distinguishes pathogenic from benign PPGL-risk variants: doi.org/10.1172/JCI1...
Here, Justin P. Annes & team report an SDHB-specific assay that distinguishes pathogenic from benign PPGL-risk variants: doi.org/10.1172/JCI1...
journals.biologists.com/jcs/article/...
#OpenAccess #JCSMitoSI #Mitochondria
journals.biologists.com/jcs/article/...
#OpenAccess #JCSMitoSI #Mitochondria
🔗 Read: doi.org/10.1530/EO-2...
🔗 Read: doi.org/10.1530/EO-2...
by Lee S, Needleman L (...) Annes JP et 4 al. in J Clin Invest #MedSky
👉 get more here
📖 read the article: https://www.jci.org/articles/view/198165
by Lee S, Needleman L (...) Annes JP et 4 al. in J Clin Invest #MedSky
👉 get more here
📖 read the article: https://www.jci.org/articles/view/198165
Enzyme assays demonstrating competitive inhibition of human ATCase activity by succinate.
Demonstrating impaired pyrimidine synthesis in a mouse model of SDHB deficient pituitary tumors.
And much more!
Enzyme assays demonstrating competitive inhibition of human ATCase activity by succinate.
Demonstrating impaired pyrimidine synthesis in a mouse model of SDHB deficient pituitary tumors.
And much more!
➡️ u.afp.com/SDhB
➡️ u.afp.com/SDhB
www.youtube.com/watch?v=sdhb...
www.youtube.com/watch?v=sdhb...
🚀 We show how SDHB mutations drive epigenetic changes and metabolic adaptation in metastatic pheochromocytomas and paragangliomas, uncovering potential therapeutic targets.
📄 www.nature.com/articles/s42...
@iuopa.bsky.social #ISPA
🚀 We show how SDHB mutations drive epigenetic changes and metabolic adaptation in metastatic pheochromocytomas and paragangliomas, uncovering potential therapeutic targets.
📄 www.nature.com/articles/s42...
@iuopa.bsky.social #ISPA
➡️ https://l.euronews.com/sdhB
➡️ https://l.euronews.com/sdhB
www.youtube.com/watch?v=SDhB...
#murphchallenge #murph #wod #crossfit #herowod
www.youtube.com/watch?v=SDhB...
#murphchallenge #murph #wod #crossfit #herowod
Roderick Clifton-Bligh discusses Sooyeon Lee et al.: doi.org/10.1172/JCI1...
Roderick Clifton-Bligh discusses Sooyeon Lee et al.: doi.org/10.1172/JCI1...